Difference between revisions of "Saillan-Barreau 2008 J Acquir Immune Defic Syndr"
From Bioblast
Harrison DK (talk | contribs) |
|||
| Line 4: | Line 4: | ||
|authors=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L | |authors=Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L | ||
|year=2008 | |year=2008 | ||
|journal=J | |journal=J Acquir Immune Defic Syndr | ||
|mipnetlab=FR_Toulouse_Casteilla L | |mipnetlab=FR_Toulouse_Casteilla L | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
}} | }} | ||
Revision as of 16:59, 7 November 2012
| Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Pénicaud L (2008) Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. J Acquir Immune Defic Syndr 48: 20-25. |
Saillan-Barreau C, Tabbakh O, Chavoin JP, Casteilla L, Penicaud L (2008) J Acquir Immune Defic Syndr
Abstract:
• O2k-Network Lab: FR_Toulouse_Casteilla L
Labels:
HRR: Oxygraph-2k
